Skip to main content

Month: June 2023

Statkraft signs long-term power contract with Hydro

(Oslo, June 8 2023) Hydro Energi AS has signed a long-term power purchase agreement (PPA) with Statkraft for the delivery of 0.44 TWh per year to Hydro’s Norwegian aluminium plants in the period from 2024-2038. The PPA secures a total supply of 6.6 TWh of renewable power over a 15-year period to Hydro’s plants in NO3 from Statkraft’s power plants in the price area. Access to renewable power and modern technology enable Hydro to produce aluminium in Norway with a carbon footprint of about 75 percent less than the global average. Long-term power agreements at competitive prices are crucial for Hydro to continue to lead the way in low-carbon aluminium globally. “Hydro has a great need for power in the future and several of our existing agreements will expire from 2030. This agreement is an important step in sourcing...

Continue reading

Nonprofits continue to struggle with rising costs and battle for talent but express cautious optimism as revenues increase, Sage research finds

Nonprofits see technological advancement as a necessity to operate today, but lack the talent to make it a priority. TORONTO, June 08, 2023 (GLOBE NEWSWIRE) — Today Sage, the leader in accounting, financial, HR, and payroll technology for small and mid-sized businesses, released the second part of its annual Grow Together report, which found that Canadian nonprofits express optimism about their financial outlook but struggle with rising costs and securing skilled talent to help drive strategic initiatives including digital transformation. As a follow-up to the Annual Grow Together report released in April 2023, which looked at charitable giving in Canada, the 2023 Grow Together: Building value for nonprofits in a digital economy – conducted by Léger – surveyed 120 decision makers in nonprofit organizations in April 2023 to gleam...

Continue reading

Esperion to Present New Key Science at the American Diabetes Association’s 83rd Scientific Sessions 2023

ANN ARBOR, Mich., June 08, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced the presentation of key late breaking sessions at the American Diabetes Association’s 83rd Scientific Sessions taking place on June 23-26, 2023, in San Diego, CA.Session Type:       Late Breaking Poster Session (printed poster)     Date/Time:   June 24, 2023, 11:30 AM – 12:30 PM PT     Abstract Title:   LDL Cholesterol Reduction and Cardiovascular Outcomes in High-Risk Primary Prevention Patients     Location:   Poster Halls B-CANDSession Type:       ePoster Theater (oral presentation)     Date/Time:   June 24, 2023 5:40 PM – 5:50 PM PT     Session Title:   New Approaches and Renewing the Old – Late Breaking Abstracts     Presentation Title:   LDL Cholesterol Reduction and Cardiovascular...

Continue reading

TransUnion Report Finds 37% Increase in Number of Property Managers Reporting Rent Payments Since Last Year

Nearly half of those who report rent payments to credit reporting agencies began doing so in 2022 CHICAGO, June 08, 2023 (GLOBE NEWSWIRE) — More than one-third (36%) of property managers who are aware of the practice of reporting rent payments to credit reporting agencies do so. The finding comes from new research from the Tenant and Employment business at TransUnion (NYSE: TRU) and represents a 37% increase from the number of property managers who said they reported such payments in 2022. Underscoring this rising trend, nearly half (48%) of those who now report rent payments began doing so in 2022—in part through solutions like TransUnion’s TruVision™ Resident Credit. The top reasons cited for reporting rent payments were to help residents build their credit scores (86%), followed by encouraging residents to pay on time...

Continue reading

Zscaler to Host Innovations Briefing for Investors at Zenith Live 2023

SAN JOSE, Calif., June 08, 2023 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that the company will host an innovations briefing for investors on June 15, 2023. The briefing will take place in Las Vegas, Nevada, during the company’s Zenith Live 2023 event. Zscaler Investor Innovations Briefing – Zenith Live 2023Thursday, June 15, 202311:00 a.m. – 1:00 p.m. PT (2:00 p.m. – 4:00 p.m. ET) A live webcast and replay will be available on the Investor Relations section of the Zscaler website at https://ir.zscaler.com. About Zscaler Zscaler (NASDAQ: ZS) accelerates digital transformation so customers can be more agile, efficient, resilient, and secure. The Zscaler Zero Trust Exchange™ platform protects thousands of customers from cyberattacks and data loss by securely...

Continue reading

SUPERIOR GROUP OF COMPANIES ANNOUCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

ST. PETERSBURG, Fla., June 08, 2023 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Michael Benstock, Chief Executive Officer, and Michael Koempel, Chief Financial Officer, will participate in the Sidoti June Virtual Investor Conference on Thursday, June 15, 2023. Management will participate in a fireside chat at 1:00 pm Eastern Time, and host virtual one-on-one and small group meetings throughout the day. Management will also present during Singular Research’s webinar on Thursday, June 22, 2023 at 11:30 am Eastern Time. Both webcasts will be available on the presentations page of the company’s investor relations website at https://ir.superiorgroupofcompanies.com/presentations. About Superior Group of Companies, Inc. (SGC):Superior Group of Companies™, established in 1920, is...

Continue reading

Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference

SAN JOSE, Calif., June 08, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that a late-breaking abstract “Oral Delivery of a GLP-1 Agonist with High Bioavailability in Dogs and Humans” has been selected for poster presentation at the American Diabetes Association’s (ADA) Scientific Sessions taking place on June 23 – 26, 2023 in San Diego, CA. The details of the presentation are as follows: Poster Title: Oral Delivery of a GLP-1 Agonist with High Bioavailability in Dogs and HumansPoster Identifier: 89-LB Poster Category: 12-D Clinical Therapeutics – Other Therapeutic AgentsDate & Time: Saturday June 24, 2023, 11:30am-12:30pm PTLocation: San Diego Convention...

Continue reading

LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

Lead development candidate selected by Janssen Biotech under research collaboration provides a milestone payment to LAVA Strong balance sheet expected to provide cash runway into 2026UTRECHT, The Netherlands and PHILADELPHIA, June 08, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma-delta T cell engagers, today announced recent corporate highlights and financial results for the quarter ended March 31, 2023. “We entered 2023 with a strengthened leadership team and have laid the foundation for a productive year,” said Stephen Hurly, president and chief executive officer of LAVA Therapeutics. “We continue to advance our clinical trials in Europe and the United States. We are also working closely...

Continue reading

Interactive Strength Inc. d/b/a FORME Reports First Quarter 2023 Results

Adjusted EBITDA was a $4.4 million loss, a $6.3 million improvement versus first quarter of 2022 Average Annualized Recurring Revenue per Household at $1,650, more than three times greater versus first quarter of 2022 New Note Purchase Agreement to issue up to $15.0 million in senior secured notes AUSTIN, TX, June 08, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Interactive Strength Inc. d/b/a FORME (the “Company”, or “FORME”) (NASDAQ: TRNR), today announced its financial results for the first quarter of 2023. The Company incurred a net loss of $16.0 million for the first quarter of 2023, or a loss of $2.09 per diluted share, as compared with a net loss of $12.7 million, or a loss of $43.81 per diluted share for the same period in 2022, due primarily to expenses incurred in connection with the Company’s IPO. Adjusted...

Continue reading

Ero Copper Announces Update on Nickel Sulphide Exploration Program — Intercepts 11.2 Meters Grading 1.86% Nickel, including 5.0 Meters Grading 3.71% Nickel

Figure 1 Rougher stage nickel recovery versus grind size.Figure 2 Drill core from the VB Zone (hole VB-41 at 392.4 meters) highlighting loop textured pentlandite.Figure 3 Drill core from the VB Zone (hole VB-41) highlighting high-grade massive sulphide within the zone from 385.0 to 396.5 meters.Figure 4 Brecciated and patchy net-textured sulphides shown in detail for hole LZ-32 (~300 meters downhole) showing both pentlandite and pyrrhotiteFigure 5 Umburana System – Plan MapFigure 6 VB Zone – Plan MapFigure 7 VB Zone – East-West Composite SectionFigure 8 LZ Zone – Plan MapFigure 9 LZ Zone – East-West Composite SectionVANCOUVER, British Columbia, June 08, 2023 (GLOBE NEWSWIRE) —  Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to provide...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.